本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cue Biopharma, Inc.

0.6952
+0.00320.46%
盤後0.6703-0.0249-3.58%15:58 EDT
成交量:6.66萬
成交額:4.64萬
市值:5,238.32萬
市盈率:-1.07
高:0.7098
開:0.6920
低:0.6700
收:0.6920
資料載入中...
2022/11/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/15

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/22

重要事件披露

8-K - Current report
2022/06/10

重要事件披露

8-K - Current report
2022/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/30

重要事件披露

8-K - Current report
2022/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]